| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |